Workup and Management for Chronic Right Leg Stiffening, Weakness, and Unsteadiness
This 59-year-old man requires urgent neurologic evaluation with MRI of the lumbosacral spine and plexus, nerve conduction studies/EMG, and comprehensive laboratory workup to differentiate between structural lesions (radiculoplexopathy), inflammatory neuropathies, and rare conditions like stiff-person syndrome.
Initial Diagnostic Approach
The sudden onset followed by 2+ years of progression with unilateral predominance points toward a structural or focal inflammatory process rather than a systemic polyneuropathy. The combination of stiffening (suggesting spasticity or rigidity) with weakness and unsteadiness requires systematic localization.
Immediate Neurologic Examination Focus
Examine for:
- Upper motor neuron signs: Hyperreflexia, spasticity, Babinski sign (suggests spinal cord or brain pathology)
- Lower motor neuron signs: Hyporeflexia/areflexia, muscle atrophy, fasciculations (suggests nerve root, plexus, or peripheral nerve)
- Sensory distribution: Dermatomal (radiculopathy), stocking-glove (polyneuropathy), or patchy (plexopathy/mononeuropathy)
- Gait pattern: Steppage gait (foot drop), spastic gait, or ataxic gait
- Muscle tone: True spasticity versus rigidity versus dystonia
Essential Imaging
MRI lumbosacral spine with and without contrast is the first-line imaging study to evaluate for:
- Structural lesions (disc herniation, spinal stenosis, tumor)
- Nerve root or plexus enlargement/enhancement (inflammatory plexopathy, tumor infiltration)
- Spinal cord pathology if upper motor neuron signs present
MRI of the lumbosacral plexus should be added if initial spine imaging is unrevealing, as plexopathies can present with unilateral leg symptoms 2.
Electrodiagnostic Studies
Nerve conduction studies and EMG are critical to:
- Distinguish demyelinating from axonal processes
- Localize to nerve root, plexus, or peripheral nerve
- Assess chronicity (acute versus chronic denervation)
- Identify patterns suggesting specific diagnoses (radiculoplexus neuropathy, chronic inflammatory demyelinating polyneuropathy)
Laboratory Workup
Order the following blood tests:
- Serum ferritin (if restless leg syndrome suspected, though less likely given weakness) 1
- HbA1c, fasting glucose (diabetic radiculoplexopathy/amyotrophy)
- Serum protein electrophoresis with immunofixation (paraproteinemic neuropathy) 5
- Anti-GAD65 antibodies (stiff-person syndrome if rigidity predominates) 6, 7
- Creatine kinase (myopathy versus neurogenic process)
- ESR, CRP, ANA, ANCA (vasculitic neuropathy)
- Vitamin B12, TSH (metabolic neuropathies)
- Anti-ganglioside antibodies if acute/subacute progression (GBS variants) 8, 9
Lumbar puncture should be performed if:
- Inflammatory polyradiculoneuropathy suspected (look for albuminocytologic dissociation: elevated protein >60 mg/dL with normal cell count) 8, 10, 4
- Infectious or malignant causes considered
Differential Diagnosis Priority
Most Likely: Lumbosacral Radiculoplexopathy
Given the chronic unilateral presentation, consider:
- Diabetic amyotrophy (lumbosacral radiculoplexus neuropathy)
- Chronic inflammatory demyelinating polyneuropathy (CIDP) with asymmetric presentation
- Structural compression (tumor, hematoma)
- Vasculitic neuropathy
Consider if Rigidity/Stiffness Predominates: Stiff-Person Syndrome
If examination reveals:
- Continuous motor unit activity on EMG
- Board-like rigidity of axial and proximal muscles
- Spasms triggered by movement or startle
- Positive anti-GAD65 antibodies
Treatment: High-dose benzodiazepines (diazepam 5-20 mg TID), baclofen (5-20 mg TID), and IVIG (0.4 g/kg/day for 5 days) 11, 6, 7
Red Flags for Guillain-Barré Syndrome Variants
Though less likely given 2-year duration, if there was acute-on-chronic worsening:
- Areflexia with ascending weakness
- Respiratory muscle involvement
- Recent infection
Treatment: IVIG (0.4 g/kg/day × 5 days) or plasmapheresis 8, 9, 10
Management Algorithm
If Structural Lesion Found on MRI:
- Neurosurgical consultation for decompression if indicated
- Treat underlying cause (tumor, abscess, hematoma)
If Inflammatory/Autoimmune Neuropathy:
- CIDP: IVIG (0.4 g/kg/day × 5 days initially, then maintenance) or plasmapheresis
- Vasculitic neuropathy: Immunosuppression (corticosteroids, cyclophosphamide)
- Paraproteinemic neuropathy: Treat underlying hematologic disorder 5
If Diabetic Radiculoplexopathy:
- Aggressive glucose control
- Pain management (gabapentin 300-1200 mg TID, pregabalin 75-300 mg BID, or duloxetine 60 mg daily)
- Physical therapy for strengthening
- Natural history: gradual improvement over 6-18 months
Symptomatic Management for Spasticity/Rigidity:
Avoid benzodiazepines during stroke recovery (if vascular etiology), but they are first-line for stiff-person syndrome 11, 7.
For spasticity from other causes:
- Tizanidine 2-4 mg TID (titrate to effect)
- Baclofen 5-20 mg TID (titrate to effect)
- Botulinum toxin injections for focal spasticity
- Physical therapy with range-of-motion exercises, stretching, positioning
Physical Rehabilitation:
- Supervised exercise therapy if vascular claudication component (though less likely given presentation) 12, 13
- Task-oriented physical therapy for motor retraining if upper motor neuron involvement 11
- Occupational therapy for functional adaptations 14
Critical Pitfalls to Avoid
Do not dismiss unilateral leg symptoms as simple musculoskeletal pain—always perform thorough neurologic examination 7, 10
Do not delay EMG/NCS—electrodiagnostic studies are essential for localization and may reveal unexpected findings like coexisting critical illness polyneuropathy 6
Do not overlook systemic features—weight loss, fever, or organomegaly suggest underlying malignancy or systemic disease 3
Do not assume symmetric presentation is required—CIDP and other inflammatory neuropathies can present asymmetrically 2, 4
Check for nodopathies (antibodies to nodal/paranodal proteins) if CIDP suspected but not responding to standard treatment—these require different management 4